Tien Liang Biotech Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 12, 2020 at 03:07 pm EDT
Share
Tien Liang BioTech Co., Ltd. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was TWD 103.721 million compared to TWD 99.326 million a year ago. Operating loss was TWD 19.223 million compared to TWD 17.825 million a year ago. Net loss was TWD 17.998 million compared to TWD 16.010 million a year ago. Basic loss per share was TWD 0.39 compared to TWD 0.35 a year ago. For the half year, sales was TWD 224.659 million compared to TWD 210.365 million a year ago. Operating loss was TWD 19.398 million compared to TWD 36.920 million a year ago. Net loss was TWD 20.076 million compared to TWD 34.320 million a year ago. Basic loss per share was TWD 0.44 compared to TWD 0.75 a year ago.
Tien Liang BioTech Co., Ltd. is a Taiwan-based company principally engaged in the manufacture, wholesale and retail of health food products. The Company is also involved in the import, wholesale and retail of western medicines, as well as the manufacture and sales of traditional Chinese medicines. The Company also provides active pharmaceutical ingredients (APIs), biopharmaceuticals and others. The Company distributes its products in domestic market.
TIEN LIANG BIOTECH CO., LTD. 
